» Articles » PMID: 25474466

Immune Status, Strain Background, and Anatomic Site of Inoculation Affect Mouse Papillomavirus (MmuPV1) Induction of Exophytic Papillomas or Endophytic Trichoblastomas

Overview
Journal PLoS One
Date 2014 Dec 5
PMID 25474466
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Papillomaviruses (PVs) induce papillomas, premalignant lesions, and carcinomas in a wide variety of species. PVs are classified first based on their host and tissue tropism and then their genomic diversities. A laboratory mouse papillomavirus, MmuPV1 (formerly MusPV), was horizontally transmitted within an inbred colony of NMRI-Foxn1(nu)/Foxn1nu (nude; T cell deficient) mice of an unknown period of time. A ground-up, filtered papilloma inoculum was not capable of infecting C57BL/6J wild-type mice; however, immunocompetent, alopecic, S/RV/Cri-ba/ba (bare) mice developed small papillomas at injection sites that regressed. NMRI-Foxn1(nu) and B6.Cg-Foxn1(nu), but not NU/J-Foxn1(nu), mice were susceptible to MmuPV1 infection. B6 congenic strains, but not other congenic strains carrying the same allelic mutations, lacking B- and T-cells, but not B-cells alone, were susceptible to infection, indicating that mouse strain and T-cell deficiency are critical to tumor formation. Lesions initially observed were exophytic papillomas around the muzzle, exophytic papillomas on the tail, and condylomas of the vaginal lining which could be induced by separate scarification or simultaneous scarification of MmuPV1 at all four sites. On the dorsal skin, locally invasive, poorly differentiated tumors developed with features similar to human trichoblastomas. Transcriptome analysis revealed significant differences between the normal skin in these anatomic sites and in papillomas versus trichoblastomas. The primarily dysregulated genes involved molecular pathways associated with cancer, cellular development, cellular growth and proliferation, cell morphology, and connective tissue development and function. Although trichoepitheliomas are benign, aggressive tumors, few of the genes commonly associated with basal cell carcinoma or squamous cells carcinoma were highly dysregulated.

Citing Articles

Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening.

Atkins H, Uslu A, Li J, Shearer D, Brendle S, Han C mBio. 2024; 15(8):e0142024.

PMID: 39012151 PMC: 11323795. DOI: 10.1128/mbio.01420-24.


Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model.

Brendle S, Li J, Walter V, Schell T, Kozak M, Balogh K Pathogens. 2023; 12(12).

PMID: 38133335 PMC: 10745854. DOI: 10.3390/pathogens12121452.


The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.

King R, Rademacher J, Ward-Shaw E, Hu R, Bilger A, Blaine-Sauer S Laryngoscope. 2023; 134(5):2322-2330.

PMID: 38084790 PMC: 11006576. DOI: 10.1002/lary.31228.


The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.

Luna A, Young J, Sterk R, Bondu V, Schultz F, Kusewitt D Antiviral Res. 2023; 216:105667.

PMID: 37429527 PMC: 10530289. DOI: 10.1016/j.antiviral.2023.105667.


Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.

Wang W, Spurgeon M, Pope A, McGregor S, Ward-Shaw E, Gronski E Proc Natl Acad Sci U S A. 2023; 120(12):e2214225120.

PMID: 36917668 PMC: 10041145. DOI: 10.1073/pnas.2214225120.


References
1.
Ross P, Cheng I, Liu X, Cicek M, Carroll P, Casey G . Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer. 2009; 9:69. PMC: 2657151. DOI: 10.1186/1471-2407-9-69. View

2.
Schulz E, Gottschling M, Wibbelt G, Stockfleth E, Nindl I . Isolation and genomic characterization of the first Norway rat (Rattus norvegicus) papillomavirus and its phylogenetic position within Pipapillomavirus, primarily infecting rodents. J Gen Virol. 2009; 90(Pt 11):2609-2614. DOI: 10.1099/vir.0.012583-0. View

3.
Forbes S, Tang G, Bindal N, Bamford S, Dawson E, Cole C . COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 2009; 38(Database issue):D652-7. PMC: 2808858. DOI: 10.1093/nar/gkp995. View

4.
Petry I, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M . ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer. Clin Cancer Res. 2010; 16(2):451-60. DOI: 10.1158/1078-0432.CCR-09-1617. View

5.
Schafer K, Waterboer T, Rosl F . A capture ELISA for monitoring papillomavirus-induced antibodies in Mastomys coucha. J Virol Methods. 2009; 163(2):216-21. DOI: 10.1016/j.jviromet.2009.09.020. View